| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
|
16.06.2025 22:00:00
|
These 2 Growth Stocks Are No-Brainer Buys Right Now
When it comes to investing, sometimes you want to take a big swing. After all, it's not always the number of winners in your portfolio that power your returns, but finding a few stocks that can be massive winners over time.Let's look at two no-brainer growth stocks that fit that bill.Hims & Hers Health (NYSE: HIMS) has quietly been not just one of the fastest-growing names in telemedicine, but in the entire market. In 2022, it grew its revenue by 94%, followed by 65% growth in 2023 and 69% in 2024. That momentum carried into the first quarter of this year, with revenue surging 111% and its subscriber base jumping 38% to 2.4 million. Meanwhile, this isn't just about top-line growth, its profitability and cash flows are also soaring. Last quarter, its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) nearly tripled year over year, while its adjusted earnings per share (EPS) and operating cash flow quadrupled. Continue readingWeiter zum vollständigen Artikel bei MotleyFool